Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3381) 3381
Book Chapter (101) 101
Book / eBook (9) 9
Dissertation (5) 5
Magazine Article (2) 2
Streaming Video (2) 2
Web Resource (2) 2
Conference Proceeding (1) 1
Journal / eJournal (1) 1
Publication (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (2895) 2895
life sciences & biomedicine (2738) 2738
humans (2637) 2637
animals (2082) 2082
mice (1420) 1420
oncology (1317) 1317
cell line, tumor (1284) 1284
oncolytic virotherapy (1190) 1190
oncolytic virotherapy - methods (1174) 1174
oncolytic viruses - genetics (1077) 1077
medicine, research & experimental (1024) 1024
research & experimental medicine (1024) 1024
cancer (1019) 1019
tumors (913) 913
biotechnology & applied microbiology (901) 901
viruses (875) 875
genetics & heredity (817) 817
female (785) 785
adenoviridae - genetics (757) 757
neoplasms - therapy (756) 756
gene therapy (754) 754
health aspects (725) 725
oncolytic virus (655) 655
xenograft model antitumor assays (648) 648
virus replication (640) 640
oncolysis (631) 631
mice, nude (626) 626
care and treatment (603) 603
immunotherapy (602) 602
research (565) 565
biological and medical sciences (519) 519
oncolytic viruses - physiology (514) 514
apoptosis (483) 483
medical sciences (470) 470
adenoviruses (465) 465
male (445) 445
genetic therapy - methods (442) 442
gene expression (413) 413
genetic aspects (398) 398
genetic vectors (389) 389
genetic vectors - genetics (379) 379
cancer therapies (356) 356
mice, inbred balb c (343) 343
adenovirus (342) 342
oncolytic viruses (341) 341
biochemistry & molecular biology (339) 339
genetics (317) 317
virology (303) 303
combined modality therapy (302) 302
genetic therapy (298) 298
proteins (297) 297
molecular biology (286) 286
chemotherapy (283) 283
oncolytic adenovirus (281) 281
pharmacology (278) 278
molecular medicine (275) 275
adenoviridae - physiology (274) 274
clinical trials (267) 267
virotherapy (256) 256
cell biology (255) 255
neoplasms - genetics (253) 253
drug discovery (252) 252
disease models, animal (246) 246
review (233) 233
original (229) 229
genetic engineering (228) 228
oncolytic viruses - immunology (227) 227
melanoma (226) 226
analysis (221) 221
infections (214) 214
neoplasms - immunology (211) 211
neoplasms - virology (211) 211
antineoplastic agents (209) 209
fundamental and applied biological sciences. psychology (208) 208
biotechnology (205) 205
oncolytic viruses - metabolism (205) 205
cytotoxicity (203) 203
usage (200) 200
cell line (199) 199
mutation (190) 190
genetic vectors - administration & dosage (188) 188
immunology (188) 188
treatment outcome (188) 188
metastasis (187) 187
microbiology (186) 186
neoplasms - pathology (186) 186
oncolytic (185) 185
tumor cells, cultured (184) 184
neoplasms. tumors. oncology. including cancer and carcinogens (182) 182
brain neoplasms - therapy (181) 181
herpesvirus 1, human - genetics (180) 180
mice, inbred c57bl (178) 178
original article (177) 177
tumor cells (171) 171
kinases (167) 167
physiological aspects (167) 167
immune response (165) 165
promoter regions, genetic (162) 162
antitumor activity (161) 161
clinical trials as topic (160) 160
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3479) 3479
Chinese (21) 21
Japanese (15) 15
Russian (13) 13
French (7) 7
German (4) 4
Hungarian (1) 1
Korean (1) 1
Polish (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Oncolytic viruses—immunotherapeutics on the rise
by Keller, Brian A and Bell, John C
Journal of molecular medicine (Berlin, Germany), ISSN 0946-2716, 9/2016, Volume 94, Issue 9, pp. 979 - 991
Human Genetics | Oncolytic viruses | Biomedicine | Immunotherapy | Internal Medicine | Molecular Medicine | Immune checkpoint inhibitors | Combination therapy | Cancer | Genetics & Heredity | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Gene Transfer Techniques | Genetic Therapy | Immunomodulation - drug effects | Gene Expression | Immunotherapy - methods | Genetic Vectors - administration & dosage | Immunotherapy, Adoptive | Humans | Oncolytic Viruses - genetics | Treatment Outcome | Clinical Trials as Topic | Combined Modality Therapy | Molecular Targeted Therapy | Biomarkers, Tumor | Genetic Vectors - genetics | Oncolytic Virotherapy - methods | Neoplasms - therapy | Animals | Neoplasms - genetics | Antineoplastic Agents, Immunological - therapeutic use | Neoplasms - immunology | Neoplasms - pathology | Transgenes | Care and treatment | Health aspects | Methods | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Recombinant Vaccinia Viruses Coding Transgenes of Apoptosis-Inducing Proteins Enhance Apoptosis But Not Immunogenicity of Infected Tumor Cells
by Koval, Olga and Kochneva, Galina and Tkachenko, Anastasiya and Troitskaya, Olga and Sivolobova, Galina and Grazhdantseva, Antonina and Nushtaeva, Anna and Kuligina, Elena and Richter, Vladimir
BioMed research international, ISSN 2314-6133, 8/2017, Volume 2017, pp. 3620510 - 14
Life Sciences & Biomedicine | Biotechnology & Applied Microbiology | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Virus Replication - genetics | Humans | Cercopithecus aethiops | Apoptosis - genetics | Vaccinia virus - genetics | Cell Death - genetics | Neoplasms - genetics | DNA Fragmentation | Caspase 3 - genetics | Apoptosis Regulatory Proteins - genetics | Membrane Potential, Mitochondrial - genetics | Female | Phosphatidylserines - genetics | bcl-2-Associated X Protein - genetics | Caspase 7 - genetics | Transgenes - genetics | Antineoplastic Agents | HSP70 Heat-Shock Proteins - genetics | Oncolytic Viruses - genetics | Up-Regulation - genetics | Mice, SCID | Genetic Vectors - genetics | Granulocyte-Macrophage Colony-Stimulating Factor - genetics | Animals | Cell Line, Tumor | Biomarkers, Tumor - genetics | Mice | Physiological aspects | Genetic aspects | Genetic engineering | DNA viruses | Recombinant proteins | Methods | Apoptosis | Biotechnology | Bax protein | Viruses | Genomes | Activation | Vaccines | Immunity | HMGB1 protein | Caspase-3 | Cancer therapies | Anticancer properties | Proteins | Mitochondria | Calreticulin | Immunotherapy | DNA fragmentation | Cell cycle | Gangrene | Oncolysis | Membrane potential | Transgenes | Phosphatidylserine | Deoxyribonucleic acid--DNA | Killing | Medical research | Granulocyte-macrophage colony-stimulating factor | Tumor cells | Mortality | Markers | Caspase | Hsp70 protein | Breast cancer | Virology | Caspase-7 | Immunogenicity | Cellular biology | Cell death | Adenoviruses | Antitumor activity | Recombinants | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Maraba Virus as a Potent Oncolytic Vaccine Vector
by Pol, Jonathan G and Zhang, Liang and Bridle, Byram W and Stephenson, Kyle B and Rességuier, Julien and Hanson, Stephen and Chen, Lan and Kazdhan, Natasha and Bramson, Jonathan L and Stojdl, David F and Wan, Yonghong and Lichty, Brian D
Molecular therapy, ISSN 1525-0016, 02/2014, Volume 22, Issue 2, pp. 420 - 429
Genetics & Heredity | Life Sciences & Biomedicine | Biotechnology & Applied Microbiology | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Lung Neoplasms - mortality | Cytopathogenic Effect, Viral | Vesiculovirus - immunology | Neoplasms - therapy | Lung Neoplasms - secondary | Melanoma, Experimental | Neoplasms - genetics | Vesiculovirus - genetics | Female | Viral Tropism | Lung Neoplasms - genetics | Gene Expression | Genetic Vectors - immunology | Neoplasms - mortality | Immunization, Secondary - methods | Oncolytic Viruses - genetics | Treatment Outcome | Lung Neoplasms - therapy | Genetic Vectors - genetics | Cancer Vaccines - immunology | Lung Neoplasms - immunology | Animals | Intramolecular Oxidoreductases - genetics | Neoplasms - immunology | Rhabdoviridae - immunology | Oncolytic Viruses - immunology | Mice | Rhabdoviridae - genetics | CD8-Positive T-Lymphocytes - immunology | Neoplasms - pathology | Index Medicus | Original
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Oncolytic virus therapy: A new era of cancer treatment at dawn
by Fukuhara, Hiroshi and Ino, Yasushi and Todo, Tomoki
Cancer science, ISSN 1347-9032, 10/2016, Volume 107, Issue 10, pp. 1373 - 1379
herpes simplex virus | Clinical trial | oncolytic immunotherapy | G47 | oncolytic virus | Life Sciences & Biomedicine | Oncology | Science & Technology | Immunotherapy - methods | Genetic Vectors - administration & dosage | Humans | Oncolytic Viruses - genetics | Treatment Outcome | Clinical Trials as Topic | Genetic Vectors - genetics | Immunotherapy - adverse effects | Oncolytic Virotherapy - methods | Neoplasms - therapy | Animals | Genetic Engineering | Neoplasms - genetics | Oncolytic Virotherapy - adverse effects | Genetic Therapy - adverse effects | Genetic Therapy - methods | Oncology, Experimental | Immunotherapy | Genetically modified organisms | Melanoma | Genetic engineering | Research | Drug therapy | Health aspects | Drug approval | Cancer | Brain cancer | Genes | Glioblastoma | Clinical trials | Herpes simplex | Hepatocellular carcinoma | Viruses | Genomes | Cancer therapies | Tropical diseases | Hepatitis | Oncolysis | Cytokines | Research & development--R&D | Bladder cancer | Patients | Fever | Immune checkpoint | Adenoviruses | Head and neck cancer | Head & neck cancer | Viral infections | Tumors | Index Medicus | Review
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Oncolytic Virotherapy: A Contest between Apples and Oranges
by Russell, Stephen J and Peng, Kah-Whye
Molecular therapy, ISSN 1525-0016, 05/2017, Volume 25, Issue 5, pp. 1107 - 1116
competitive landscape | oncolytic virotherapy | viro-immuno-oncology | T-VEC | Genetics & Heredity | Life Sciences & Biomedicine | Biotechnology & Applied Microbiology | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Lymph Nodes - pathology | Humans | Mutant Chimeric Proteins - genetics | Plasmacytoma - genetics | Multiple Myeloma - immunology | Plasmacytoma - immunology | Plasmacytoma - pathology | Measles virus - genetics | Multiple Myeloma - therapy | Antigen Presentation | Melanoma - genetics | Mutant Chimeric Proteins - metabolism | T-Lymphocytes - pathology | Skin Neoplasms - pathology | Antigens, Neoplasm - genetics | Oncolytic Virotherapy - trends | Genetic Vectors - chemistry | Herpesvirus 1, Human - metabolism | Skin Neoplasms - immunology | Skin Neoplasms - therapy | Antigens, Neoplasm - immunology | Genetic Vectors - metabolism | Oncolytic Viruses - genetics | Lymph Nodes - immunology | Melanoma - pathology | Oncolytic Virotherapy - methods | Multiple Myeloma - pathology | Measles virus - metabolism | Melanoma - immunology | Oncolytic Viruses - immunology | Plasmacytoma - therapy | Skin Neoplasms - genetics | Herpesvirus 1, Human - genetics | T-Lymphocytes - immunology | Melanoma - therapy | Multiple Myeloma - genetics | Tumor cells | Immunomodulation | Melanoma | Antibodies | Viruses | Lymphocytes T | Kinases | Macrophages | Lymph nodes | Skin cancer | Metastases | Immune checkpoint | Immunotherapy | Antigen (tumor-associated) | Oncolysis | Index Medicus | Review
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Oncolytic viruses: adenoviruses
by Niemann, Julia and Kühnel, Florian
Virus genes, ISSN 0920-8569, 10/2017, Volume 53, Issue 5, pp. 700 - 706
Retargeting | Medical Microbiology | Arming | Biomedicine | Adenovirus | Checkpoint inhibition | Conditional replication | Oncolytic virus | Plant Sciences | Virology | Genetics & Heredity | Life Sciences & Biomedicine | Science & Technology | Neoplasms - virology | Oncolytic Virotherapy - methods | Neoplasms - therapy | Animals | Humans | Adenoviridae - genetics | Oncolytic Viruses - genetics | Genetic Vectors - genetics | Genetic Therapy - methods | Virus diseases | Medical colleges | Viral proteins | Adenoviruses | Melanoma | Health aspects | Tumors | Cytolysis | Immune response | Immunostimulation | Immunotherapy | Lysis | Clinical trials | Oncolysis | Viruses | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Pre-existing Immunity to Oncolytic Virus Potentiates Its Immunotherapeutic Efficacy
by Ricca, Jacob M and Oseledchyk, Anton and Walther, Tyler and Liu, Cailian and Mangarin, Levi and Merghoub, Taha and Wolchok, Jedd D and Zamarin, Dmitriy
Molecular therapy, ISSN 1525-0016, 04/2018, Volume 26, Issue 4, pp. 1008 - 1019
NDV | tumor immunology | oncolytic virus | pre-existing immunity | Newcastle Disease Virus | cancer immunotherapy | immuno-oncology | Genetics & Heredity | Life Sciences & Biomedicine | Biotechnology & Applied Microbiology | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | T-Lymphocyte Subsets - immunology | Genetic Vectors - administration & dosage | Humans | Genetic Vectors - adverse effects | Lymphocyte Activation - genetics | Lymphocyte Activation - immunology | Neoplasms - therapy | Melanoma, Experimental | Injections, Intralesional | Newcastle disease virus - immunology | Transgenes | Oncolytic Virotherapy - adverse effects | Disease Models, Animal | Adaptive Immunity | Gene Expression | Genetic Vectors - immunology | Oncolytic Viruses - genetics | Treatment Outcome | Genetic Vectors - genetics | Xenograft Model Antitumor Assays | Animals | Neoplasms - immunology | T-Lymphocyte Subsets - metabolism | Newcastle disease virus - genetics | Oncolytic Viruses - immunology | Cell Line, Tumor | Mice | Neoplasms - pathology | Genetic Therapy - adverse effects | Genetic Therapy - methods | Potentiation | Medical research | Antiviral agents | Immunoglobulins | Animal models | Immune response | Laboratories | Immune clearance | Melanoma | Viruses | Infections | FDA approval | Gene expression | Patients | Experiments | Ovarian cancer | Newcastle disease | Immunotherapy | Oncolysis | Viral infections | Immune system | Tumors | Index Medicus | Original
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights